Steven L. Hoerter, See Remarks at Clovis Oncology, Inc. (CLVS), sold 20,000 shares at $80.00 ($1.6M) on 2015-03-05, disclosed to the SEC on 2015-03-09.
Scheduled sale ($1.6M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| DCPH | SELL | 2023-10-31 | $519K | — | Filing → |
| DCPH | SELL | 2023-03-23 | $117K | — | Filing → |
| DCPH | SELL | 2023-02-16 | $481K | — | Filing → |